Resultados de la búsqueda 161-170 of 11962 for B cell lymphomas
Giving rituximab together with romidepsin and lenalidomide may be a better treatment for B-cell non-Hodgkin lymphoma. A Study to Evaluate Colorectal Polyps with ...
Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma. Rochester, Minn., Mankato, Minn., La Crosse ...
In-depth · B-cell lymphoma · Burkitt lymphoma · Cáncer · Endocarditis · Enfermedad de Castleman · Fiebre del valle · Ganglios linfáticos inflamados · Insuficiencia ...
... b-cell lymphoma (DLBCL) patients with out of specification leukapheresis product and/or manufactured tisagenlecleucel out of specification for commercial ...
1 cells administered following a conditioning lymphodepletion regimen in diffuse large B cell lymphoma (DLBCL) subjects who failed at least two lines of ...
... b-cell lymphoma (DLBCL) patients with out of specification leukapheresis ... The purpose of this study is to collect vaginal and endometrial cell samples to study ...
Rochester, Minn. The purpose of this study is to evaluate the immune and hematopoietic compartments in patients with monoclonal B cell lymphocytosis (MBL) and ...
... B-cell Acute Lymphoblastic Leukemia (B-ALL) improves outcomes. ... lymphoma (B-LLy) when treated with ALL therapy without inotuzumab ozogamicin. ... lymphoma (B ...
... cells to grow and spread. Chemotherapy ... Axicabtagene Ciloleucel versus Standard of Care Therapy as First-Line Therapy in High-Risk Large B-Cell Lymphoma.
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?